Asano Y, Hodes R J
J Exp Med. 1985 Aug 1;162(2):413-26. doi: 10.1084/jem.162.2.413.
Previous studies have shown the existence of both heterogeneous Lyt-1-,2+ suppressor (Ts) cells and cloned Lyt-1+,2- Ts cells which, despite the difference in their Lyt phenotypes, functioned in a similar antigen-specific and major histocompatibility complex (MHC)-restricted fashion to suppress the antibody responses generated by cloned helper T (Th) cells and hapten-primed B cells. Our studies were carried out to assess in further detail the genetically restricted cell interactions that mediate this immune response suppression. We show that the activation of both heterogeneous and cloned Ts cells is antigen-specific and MHC-restricted under our experimental conditions. After appropriate activation, the effector function of both cloned Lyt-1+,2-Ts cells and heterogeneous Lyt-1-,2+ Ts cells was also antigen-specific. In contrast, once activated, Ts cells suppressed the responses generated by cloned Th cells and hapten-primed B cells in an MHC-unrestricted fashion. We also showed, however, that a population of unprimed Lyt-1+,2-T cells was able to significantly alter the genetic restriction requirements for Ts cell function. The activity of this population was itself MHC-restricted, and was observed only when the unprimed Lyt-1+,2-T cells shared the MHC restriction specificity of the cloned Th cells functioning in a given response. When these requirements were satisfied, Lyt-1+,2- T cells significantly modified the suppression mediated by both heterogeneous and cloned Ts cells, resulting in suppression that was then MHC restricted in its effector function as well as in its activation requirements. Thus, our findings suggest that the observed MHC restriction in Ts function is the result of a complex interaction involving Ts cells, Th cells, and an additional population of MHC-restricted Lyt-1+,2- T cells. This newly characterized activity of Lyt-1+,2- T cells functionally resembles that of an MHC-restricted contrasuppressor population that selectively blocks a pathway of MHC-unrestricted Ts activity, while leaving intact susceptibility to MHC-restricted Ts effects.
先前的研究表明,存在异质性Lyt-1-、2+抑制性(Ts)细胞和克隆化的Lyt-1+、2-Ts细胞,尽管它们的Lyt表型不同,但它们以相似的抗原特异性和主要组织相容性复合体(MHC)限制性方式发挥作用,以抑制克隆化辅助性T(Th)细胞和半抗原致敏B细胞产生的抗体反应。我们开展研究以更详细地评估介导这种免疫反应抑制的基因限制性细胞相互作用。我们发现,在我们的实验条件下,异质性和克隆化Ts细胞的激活都是抗原特异性和MHC限制性的。经过适当激活后,克隆化的Lyt-1+、2-Ts细胞和异质性Lyt-1-、2+ Ts细胞的效应功能也是抗原特异性的。相比之下,一旦被激活,Ts细胞以MHC非限制性方式抑制克隆化Th细胞和半抗原致敏B细胞产生的反应。然而,我们还发现,一群未致敏的Lyt-1+、2-T细胞能够显著改变Ts细胞功能的基因限制性要求。这群细胞的活性本身是MHC限制性的,并且只有当未致敏的Lyt-1+、2-T细胞与在特定反应中发挥作用的克隆化Th细胞具有相同的MHC限制性特异性时才会观察到。当这些条件满足时,Lyt-1+、2-T细胞会显著改变异质性和克隆化Ts细胞介导的抑制作用,导致抑制作用在效应功能及其激活要求方面都受到MHC限制。因此,我们的研究结果表明,观察到的Ts功能中的MHC限制是涉及Ts细胞、Th细胞以及另一群MHC限制性Lyt-1+、2-T细胞的复杂相互作用的结果。Lyt-1+、2-T细胞的这种新发现的活性在功能上类似于MHC限制性抗抑制细胞群的活性,该细胞群选择性地阻断MHC非限制性Ts活性的途径,同时保持对MHC限制性Ts效应的敏感性。